Quick Answer
TransMedics Group, Inc. reported Common Stock Shares Outstanding of 34.27 million shares for the year ending 2025.
- TransMedics Group, Inc. showed an increase of +1.9% in Common Stock Shares Outstanding from 2024 to 2025.
- This data is from TransMedics Group, Inc.'s annual report (Form 10-K), filed with the SEC on February 24, 2026.
- XBRL data for this metric is available from 2020 to 2025 (6 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q4 2018: 1.40 million shares | Q1 2019: 1.43 million shares | Q2 2019: 21.10 million shares | Q4 2019: 21.18 million shares | Q1 2020: 21.34 million shares | Q2 2020: 27.14 million shares | Q3 2020: 27.16 million shares | Q1 2021: 27.48 million shares | Q2 2021: 27.65 million shares | Q3 2021: 27.76 million shares | Q1 2022: 27.97 million shares | Q2 2022: 28.02 million shares | Q3 2022: 31.93 million shares | Q1 2023: 32.53 million shares | Q2 2023: 32.58 million shares | Q3 2023: 32.64 million shares | Q1 2024: 32.85 million shares | Q2 2024: 33.31 million shares | Q3 2024: 33.56 million shares | Q1 2025: 33.83 million shares | Q2 2025: 34.04 million shares | Q3 2025: 34.14 million shares.
- Over the full 6 years of available data (2020 to 2025), TransMedics Group, Inc.'s Common Stock Shares Outstanding has grown by 26.1%.
- Historical annual values: Fiscal year 2025: 34.27 million shares | Fiscal year 2024: 33.62 million shares | Fiscal year 2023: 32.67 million shares | Fiscal year 2022: 32.14 million shares | Fiscal year 2021: 27.79 million shares | Fiscal year 2020: 27.18 million shares.
- Data sourced from SEC EDGAR public filings as of August 9, 2026.
Last verified: